MMP9 and cervical cancer: miR-221/222 have been demonstrated to target the 3′ untranslated regions (UTR) of TIMP3 in cervical cancer and lead to an increase in the levels of MMP2 and MMP9, as well as the promotion of cell migration and invasion in cervical cancer [76].